NCT06987175 Effects of Sedante Neo Therapy on Pain, Range of Motion and Quality of Life in Patients With Non Specific Low Back Pain.
| NCT ID | NCT06987175 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-15 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
this study is to evaluate the effects of SADANTE neo therapy on pain, range of motion and quality of life in patients with non-specific low back pain.
Eligibility Criteria
Inclusion Criteria: * Age group of 20 yeras to 40 years. * Both male and female included. * Having non-specific low back pain. * Having SF-MPQ score 1and 2 (1 means mild, 2 means moderate) * Having ODI score 5 to 24 * Having SF-36 healty survey score below 50 * Having range of motion below normal. Exclusion Criteria: * Below 20 years and above 40 years patient are excluded * Cervical, knee pain and other conditions excluded. * Children are excluded * Red flags ( tuberculosis, carcinoma heart disease etc) excluded -Open sores * Psychiatric diseases such as depression, phobias * Patient with history of surgery in lumber region
Contact & Investigator
Ameena Amjad, Phd
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06987175 clinical trial?
This trial is open to participants of all sexes, aged 20 Weeks or older, up to 40 Weeks, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06987175 currently recruiting?
Yes, NCT06987175 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06987175 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06987175 clinical trial?
NCT06987175 is sponsored by Riphah International University. The principal investigator is Ameena Amjad, Phd at Riphah International University. The trial plans to enroll 40 participants.